Pomerantz LLP News Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Toronto-Dominion Bank - TD

Fri, 06 Dec 2024 16:23:00 -0500

New York, New York--(Newsfile Corp. - December 6, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Toronto-Dominion Bank ("TD Bank" or the "Company") (NYSE: TD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns...

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Toronto-Dominion Bank - TD

Thu, 05 Dec 2024 16:22:00 -0500

New York, New York--(Newsfile Corp. - December 5, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Toronto-Dominion Bank ("TD Bank" or the "Company") (NYSE: TD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns...

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Toronto-Dominion Bank - TD

Thu, 21 Nov 2024 14:21:00 -0500

New York, New York--(Newsfile Corp. - November 21, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Toronto-Dominion Bank ("TD Bank" or the "Company") (NYSE: TD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns...

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against 2U, Inc. - TWOU

Wed, 07 Aug 2024 12:25:00 -0400

New York, New York--(Newsfile Corp. - August 7, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against 2U, Inc. ("2U" or the "Company") (NASDAQ: TWOU) (OTC Pink: TWOUQ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE

Mon, 05 Aug 2024 17:12:00 -0400

New York, New York--(Newsfile Corp. - August 5, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ: SKYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Skye and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about joining the class...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RH - RH

Mon, 05 Aug 2024 17:05:00 -0400

New York, New York--(Newsfile Corp. - August 5, 2024) - Pomerantz LLP is investigating claims on behalf of investors of RH ("RH" or the "Company") (NYSE: RH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether RH and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 13, 2024,...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ovid Therapeutics Inc. - OVID

Mon, 05 Aug 2024 17:01:00 -0400

New York, New York--(Newsfile Corp. - August 5, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Ovid Therapeutics Inc. ("Ovid" or the "Company") (NASDAQ: OVID). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Ovid and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Salesforce, Inc. - CRM

Mon, 05 Aug 2024 16:58:00 -0400

New York, New York--(Newsfile Corp. - August 5, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Salesforce, Inc. ("Salesforce" or the "Company") (NYSE: CRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Salesforce and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about joining the...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL

Mon, 05 Aug 2024 16:53:00 -0400

New York, New York--(Newsfile Corp. - August 5, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmaceuticals, Inc. ("Zentalis" or the "Company") (NASDAQ: ZNTL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Zentalis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Wolfspeed, Inc. - WOLF

Mon, 05 Aug 2024 16:51:00 -0400

New York, New York--(Newsfile Corp. - August 5, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Wolfspeed, Inc. ("Wolfspeed" or the "Company") (NYSE: WOLF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.The investigation concerns whether Wolfspeed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about joining the class...